Bevacizumab and neovascular age related macular degeneration
The pathogenesis of neovascular age related macular degeneration (AMD) is multifactorial including inflammation and angiogenesis leading to choroidal neovascularization (CNV). Therapy against vascular endothelial growth factor (VEGF) has revolutionized the treatment of neovascular AMD. Intravitreal...
Saved in:
| Main Author: | El Mollayess, Georges (author) |
|---|---|
| Other Authors: | Noureddine, Baha' N. (author), Bashshur, Ziad F. (author) |
| Format: | article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/10725/14186 https://doi.org/10.3109/08820538.2010.545100 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.tandfonline.com/doi/abs/10.3109/08820538.2010.545100?journalCode=isio20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal bevacizumab in the management of neovascular age-related macular degeneration
by: El-Mollayess, Georges M.
Published: (2013) -
Bevacizumab for neovascular age-related macular degeneration (ABC trial)
by: Ghazi, Nicola G.
Published: (2014) -
Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration
by: El-Mollayess, Georges M.
Published: (2012) -
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
by: Ghazi, Nicola G.
Published: (2010) -
Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
by: Ghazi, Nicola G.
Published: (2001)